دورية أكاديمية
Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.
العنوان: | Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience. |
---|---|
المؤلفون: | Herman WH; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: wherman@umich.edu., Villatoro C; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA., Joiner KL; Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA., McEwen LN; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA. |
المصدر: | Journal of diabetes and its complications [J Diabetes Complications] 2023 Aug; Vol. 37 (8), pp. 108527. Date of Electronic Publication: 2023 Jun 08. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: New York, NY : Elsevier Science Pub. Co., c1992- |
مواضيع طبية MeSH: | Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/prevention & control , Prediabetic State*/complications , Prediabetic State*/epidemiology , Prediabetic State*/therapy, Adult ; Humans ; Glycated Hemoglobin ; Nitro Compounds ; Male ; Female |
مستخلص: | Aims: To evaluate retention and outcomes of insured adults with prediabetes who enrolled or did not enroll in National Diabetes Prevention Programs (NDPPs). Methods: Between 2015 and 2019, 776 University of Michigan employees, dependents, and retirees with prediabetes and overweight or obesity enrolled in one-year NDPPs. Results: Enrollees attended a median of 18 sessions. Median retention was 38 weeks. Retention was associated with older age, greater initial weight loss, and physical activity. At both 1- and 2-years, body mass index, triglycerides, and HbA1c were significantly improved among enrollees. After adjusting for age group, sex, and race, the odds of developing diabetes based on HbA1c ≥6.5 % was 40 % lower at 1-year and 20 % lower at 2-years, and the odds of self-reported diabetes was 57 % lower at 1-year and 46 % lower at 2-years in enrollees compared to non-enrollees. Enrollees who disenrolled before completing the core curriculum had higher odds and enrollees who completed the NDPP had lower odds of developing diabetes that non-enrollees. Conclusions: In this population with prediabetes, NDPP retention was generally good, risk factors were improved, and diabetes was delayed or prevented for up to two years. Competing Interests: Declaration of competing interest No potential conflicts of interest were reported. (Copyright © 2023. Published by Elsevier Inc.) |
References: | Diabetes Care. 2020 Sep;43(9):2042-2049. (PMID: 32616617) J Diabetes Res. 2022 Feb 1;2022:2942918. (PMID: 35118160) J Diabetes Complications. 2022 Jul;36(7):108220. (PMID: 35613987) Diabetes Care. 2017 Oct;40(10):1331-1341. (PMID: 28500215) Ann Intern Med. 2005 Mar 1;142(5):323-32. (PMID: 15738451) Diabetes Care. 2023 Feb 1;46(2):255-261. (PMID: 36701592) JAMA Netw Open. 2019 May 3;2(5):e193160. (PMID: 31074808) Am J Prev Med. 2013 Apr;44(4 Suppl 4):S346-51. (PMID: 23498297) Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. (PMID: 26377054) Lancet Reg Health Eur. 2022 May 29;19:100420. (PMID: 35664052) JAMA Intern Med. 2017 Dec 1;177(12):1808-1817. (PMID: 29114778) N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527) Diabetes Care. 2018 Jul;41(7):1526-1534. (PMID: 29934481) Diabetes Care. 2021 Jul;44(7):1532-1539. (PMID: 34016617) |
معلومات مُعتمدة: | P30 DK020572 United States DK NIDDK NIH HHS; R01 DK109995 United States DK NIDDK NIH HHS; U18 DP006712 United States DP NCCDPHP CDC HHS |
فهرسة مساهمة: | Keywords: Diabetes incidence; Lifestyle intervention; Prediabetes; Prospective observational study; Retention; Type 2 diabetes prevention |
المشرفين على المادة: | 2138-40-1 (4-nitro-3-dimethylaminopropiophenone) 0 (Glycated Hemoglobin) 0 (Nitro Compounds) |
تواريخ الأحداث: | Date Created: 20230717 Date Completed: 20230811 Latest Revision: 20240807 |
رمز التحديث: | 20240807 |
مُعرف محوري في PubMed: | PMC10928673 |
DOI: | 10.1016/j.jdiacomp.2023.108527 |
PMID: | 37459781 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1873-460X |
---|---|
DOI: | 10.1016/j.jdiacomp.2023.108527 |